AllianceBernstein’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-30,400
| Closed | -$68.7K | – | 3233 |
|
|
2023
Q1 | $68.7K | Hold |
30,400
| – | – | ﹤0.01% | 3061 |
|
|
2022
Q4 | $106K | Buy |
30,400
+12,500
| +70% | +$43.6K | ﹤0.01% | 3110 |
|
|
2022
Q3 | $663K | Sell |
17,900
-59,132
| -77% | -$2.19M | ﹤0.01% | 2504 |
|
|
2022
Q2 | $1.46M | Buy |
77,032
+59,132
| +330% | +$1.12M | ﹤0.01% | 2141 |
|
|
2022
Q1 | $483K | Hold |
17,900
| – | – | ﹤0.01% | 2689 |
|
|
2021
Q4 | $403K | Hold |
17,900
| – | – | ﹤0.01% | 2816 |
|
|
2021
Q3 | $469K | Hold |
17,900
| – | – | ﹤0.01% | 2768 |
|
|
2021
Q2 | $573K | Buy |
17,900
+2,200
| +14% | +$70.4K | ﹤0.01% | 2747 |
|
|
2021
Q1 | $553K | Hold |
15,700
| – | – | ﹤0.01% | 2613 |
|
|
2020
Q4 | $503K | Sell |
15,700
-1,700
| -10% | -$54.5K | ﹤0.01% | 2581 |
|
|
2020
Q3 | $655K | Sell |
17,400
-600
| -3% | -$22.6K | ﹤0.01% | 2388 |
|
|
2020
Q2 | $806K | Buy |
+18,000
| New | +$806K | ﹤0.01% | 2298 |
|